Ruggiero Angelo
107PUBLICATIONS
62CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (107)
Sort by Publication Date:
|Aug 12, 2025
Effectiveness and Safety of Tildrakizumab in Elderly and Frail Elderly Psoriatic Patients Up to 2 years.Luca Mastorino, Paolo Dapavo, Martina Burlando
|Oct 14, 2024
Impact of tildrakizumab on the quality of life of patients with moderate-to-severe psoriasis: a 36-week prospective monocentric real-life observational study.Sara Cacciapuoti, Teresa Battista, Luca Potestio
|Sep 14, 2024
Cutaneous Squamous Cell Carcinoma: From Diagnosis to Follow-Up.Rosita Comune, Angelo Ruggiero, Antonio Portarapillo
|Jun 04, 2024
Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration - A Case Report.Fabrizio Martora, Maria Carmela Annunziata, Luca Potestio
|May 13, 2024
Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study.Matteo Megna, Angelo Ruggiero, Nello Tommasino
Pageof 18
Frequent Collaborators
49 joint publications
Matteo Megna
47 joint publications
Luca Potestio
40 joint publications
Fabrizio Martora
19 joint publications
Gabriella Fabbrocini
17 joint publications
Claudio Marasca
17 joint publications
Elisa Camela
15 joint publications
Alessia Villani
6 joint publications
Eleonora Cinelli
5 joint publications
Maddalena Napolitano
4 joint publications
Sonia Sofia Ocampo-Garza
